Maharashtra deputy chief minister Eknath Shinde has directed the state health department to include rare diseases under the Mahatma Jyotirao Phule Jan Arogya Yojana (MJPJAY), according to a statement. The move is aimed at ensuring timely diagnosis and effective treatment for patients with rare diseases such as Spinal Muscular Atrophy (SMA) and at preventing expensive medical care from burdening their families.

Shinde also asked the department to prepare a comprehensive standard operating procedure for treating SMA patients and to strengthen early diagnosis, patient registration and treatment processes. The directions followed a Wednesday meeting where officials discussed the status of SMA patients in Maharashtra, diagnosis, available treatment options, medicine availability and the challenges patients face.

The central government has selected KEM Hospital in Mumbai as the Centre of Excellence for Maharashtra, undertaking diagnosis of rare diseases, patient registration and related treatment procedures. The statement said a clearly defined protocol is necessary so that patients receive treatment more easily and in time. Treatment facilities for SMA are also available at Wadia Children's Hospital in Mumbai, and Shinde directed the department to prepare a proposal for the Union Health Ministry seeking Centre of Excellence status for the hospital as well, saying he would write to the Union health minister and follow up on the matter.

Shinde further directed the department to start the process of including the disease under MJPJAY so that treatment is not delayed due to financial constraints. He also said KEM Hospital should add the essential medicines required for treating the disease to its essential medicines list and procure them accordingly.